PVLA Stock Price
Palvella Therapeutics, Inc.
PVLA stock price is $131.34 (+0.57% on the day), giving Palvella Therapeutics, Inc. a market cap of $1.88B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
PVLA Stock Overview
- Price
- $131.34
- Previous close
- $130.59
- Open
- $129.90
- Market cap
- $1.88B
- P/E ratio
- -45.1
- 52-week range
- $59.16 - $161.38
- 1-year price target
- $229.19
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSD
- MarketXLS Rank
- 41
About Palvella Therapeutics, Inc.
Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases. Its lead product candidate is QTORIN 3.9% rapamycin anhydrous gel (QTORIN rapamycin) that is in Phase 3 clinical trial for the treatment of microcystic lymphatic malformations, as well as in Phase 2 clinical trial to treat cutaneous venous malformations. It also develops QTORIN rapamycin for the treatment of other mTOR-driven skin diseases. The company is based in Wayne, Pennsylvania.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PVLA | $131.34 | +0.6% | 208.51K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Palvella Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW